Gabriella Righetti
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Nephrology top 10%
- Parathyroid Disorders and Treatments
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
-
- Multiple Myeloma Research and Treatments 2
- Co-authors
- Maria Stella Graziani (6 shared papers)Francesca Lavatelli (1 shared paper)Remigio Moratti (1 shared paper)Cristina Marchetti (4 shared papers)Tiziana Bosoni (1 shared paper)Mario Nuvolone (1 shared paper)Giovanni O. Palladini (1 shared paper)Giampaolo Merlini (1 shared paper)
- Journals
- Clinical Chemistry (5 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (3 papers)European Journal of Epidemiology (2 papers)Neurological Sciences (1 paper)The Lancet (1 paper)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Gabriella Righetti
16 papers receiving 460 citations
Peers
Comparison fields: 5 of 58
- Hematology 131
- Nephrology 55
- Genetics 50
- Molecular Biology 254
- Oncology 65
Countries citing papers authored by Gabriella Righetti
This map shows the geographic impact of Gabriella Righetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriella Righetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriella Righetti more than expected).
Fields of papers citing papers by Gabriella Righetti
This network shows the impact of papers produced by Gabriella Righetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriella Righetti. The network helps show where Gabriella Righetti may publish in the future.
Co-authors
The 25 scholars most cited alongside Gabriella Righetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 220 | |
| 2 | 1998 | 72 | |
| 3 | 2020 | 51 | |
| 4 | 2020 | 49 | |
| 5 | 1998 | 29 | |
| 6 | 1991 | 12 | |
| 7 | Lipoprotein(a) concentrations are increased in patients with myocardial infarction and angiographically normal coronary arteries. | 1993 | 10 |
| 8 | 1994 | 8 | |
| 9 | 1989 | 7 | |
| 10 | 2008 | 6 | |
| 11 | [L-carnitine for the treatment of acute myocardial infarct]. | 1990 | 5 |
| 12 | 1984 | 4 | |
| 13 | 1987 | 3 | |
| 14 | 1989 | 3 | |
| 15 | 1988 | 1 | |
| 16 | Accuracy of cholesterol measurements in Italian clinical laboratories. Joint project GISSI prevention--Italian Society of Clinical Biochemistry. SIBioC GISSI Prevenzione Group. | 1997 | 1 |
About Gabriella Righetti
Gabriella Righetti is a scholar working on Endocrinology, Diabetes and Metabolism, Hematology, Surgery, Cardiology and Cardiovascular Medicine and Clinical Biochemistry, having authored 16 papers that have together received 481 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers), Multiple Myeloma Research and Treatments (2 papers), Microfluidic and Bio-sensing Technologies (1 paper), Cardiovascular Function and Risk Factors (1 paper), vaccines and immunoinformatics approaches (1 paper) and Cystic Fibrosis Research Advances (1 paper). The work is most often cited by research in Hematology (131 citations), Nephrology (55 citations), Genetics (50 citations), Molecular Biology (254 citations) and Oncology (65 citations). Gabriella Righetti has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Maria Stella Graziani, Francesca Lavatelli, Remigio Moratti, Cristina Marchetti, Tiziana Bosoni, Mario Nuvolone, Giovanni O. Palladini, Giampaolo Merlini, Maddalena Marini and G.V. Melzi d’Eril. Their work appears in journals such as Clinical Chemistry, Clinical Chemistry and Laboratory Medicine (CCLM), European Journal of Epidemiology, Neurological Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.